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EFFECTS OF VARIOUS TREATMENTS ON THE
DISTRIBUTION INRATS OF IMMUNE
COMPLEXES CONTAINING ANTIGENS
OF MuLVLEUKEMIAVIRUS
WAIL M. SIAG, JEAN MATCHETT,and JOE M. JONES
Departments of Microbiology and Immunology and Pathology
University of Arkansas for Medical Sciences
Little Rock, Arkansas 72205
ABSTRACT
Immune complexes (IC) containing antigens of MuLV (12S lp30-anti-p30 or 125 lgp70-anti-gp70) and
formed in vitro or invivo were sequestered primarily inthe spleen. Treatments ofrats with trypan blue,
known toinhibit the reticuloendothelial system (RES) and diethylstilbestrol (DES), known to stimulate the
RES, resulted in slight but not significant reduction of uptake of IC by the spleen. Splenectomy did not
increase sequestration of IC by the liver nor didit change the distribution of IC in other tissues. Protein
A,a cell wall protein of Staphylococcus aureus, when injected with IC resulted in a 10-fold reduction
of uptake ofIC by the spleen. This effect was seen at 4 hours, 1 day, and 8 days after injection. Protein
A did not change the binding of antigen to its respective antibody. The mechanism whereby Protein A
exerts its effect is discussed.
INTRODUCTION
Circulating immune complexes (C1C) have been implicated in the
pathogenesis of several diseases including SLE, thyroiditis,
glomerulonephritis, and cancer (Heir et al., 1977; Zanetti et al., 1977;
Kalderon and Bogaars, 1977). Removal of these CIC could prove
beneficial to patients. Terman et al. (1981) and Bansal et al. (1978) have
shown that removal ofCIC byextracorporeal perfusion of plasma from
cancer patients over a paste of Staphylococcus aureus containing
Protein A improved the conditions of these patients. We report here
the effects ofseveral treatments on the distribution in rats of ICcon-
taining antigens ofmurine leukemia virus (MuLV).
MATERIALSANDMETHODS
Animals: Brown Norway (BN rats, 3-6 months old, were obtained
from our breeding colony and from Charles River Breeding Co. They
were maintained on Purina Chow and water ad libitum.
Antigens and Antibodies: p30 and gp70 are core and viral envelope
polypeptides of MuLV, respectively. They were labeled with 1-125
using Chloramine T (McConahey and Dixon, 1966). Antibodies (BN
anti-MST) to these antigens were formed in BN rats after several
subcutaneous injections of subthreshold doses ofMoloney sarcoma cells
which express p30 and gp70. Antibody titers were assessed by radio-
immunoassay (Jones et al., 1977).
Formation and Administration of IC: Immune complexes were
made at equivalence by incubating 100/xl of BN anti-MST with 20 ng
of mI-p30 or l!!I-gp70 for 30 minutes at room temperature. Immune
complexes thus formed were injected alone into normal BN rats or were
coupled to 500/ig of Protein A (Forsgren and Sjoquist, 1978; Sjoquist
et al., 1972) for 15 minutes at room temperature before injection. A
group of tumor bearing BN rats that had high antibody titer to p30
antigen was injected with 20 ng of w'I-p30. Animals were sacrificed
24 hours later unless otherwise indicated, and their body organs were
collected, weighed and the radioactivity measured ina gamma counter.
Blood ratios of these organs were calculated bydividingcpm/g of organ
by cpm/g blood. Control groups ofanimals received the antigens in
normal BN serum or saline.
To assess the effect of other treatments on the distribution of IC,
BN rats were injected i.p. with trypan blue (RES depressant) sus-
pended in PBS (50 mg at minus 24 hours and 10 mg at minus 4 hours
to each animal)before injection of IC(Haskillet al., 1979). Other groups
were injected s.c. with diethylstilbestrol (RES stimulant) dissolved in
95% ethanol (100 mg DES/Kg body weight) 3 days before injection
ofIC (Warr and Sljivic,1973). Other groups were splenectomized under
ether anesthesia 2 days before injection of IC.
RESULTS ANDDISCUSSION
Immune complexes that formed in vivo when mI-p30 was injected
into immune tumor bearing BN rats were found to be sequestered in
the spleen at one and 9 days later (Figure 1). Other tissues did not
exhibit a significant uptake. The experiments described below repre-
sent attempts to alter this distribution using IC formed invitro and in-
jected into normal rats.
Figure 1. Distribution of mI-p30 after injection into tumor bearing
(immune) or normal BN rats. p30 (100 ng, approximately 2x10' CPM)
injected i.v. 15 days after s.c. injection of5xlO6 MST cells, or into
untreated BN rats. Columns indicate average of2 to 5 rats (± range
or standard error). Tissue/blood ratios shown for spleen, liver, cervical
nodes, lung and thymus; samples collected 1 or 9 days after ml-p30
injection.
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Treatment with trypan blue (RES depressant) orDES (RES stimulant)
reduced slightly the uptake ofICby spleen as shown inTable 1. Neither
agent altered significantly the overall tissue distribution ofIC.Ineach
case, the spleen exhibited the greatest uptake of ICper unit weight.
Splenectomy did not increase the sequestration of ICby the liverand
the absence of the spleen did notchange significantly the distribution
of ICin other tissues (Table 1).
Sequestration ofICcontaining p30 or gp70 in spleens ofBNrats was
dramatically reduced when coupled to 500 jig Protein A (Tables 1,2).
The effect ofProtein A on the reduction of spleen uptake of IC was
seen at all time intervals after 1hour (Figure 2). mI-p30 or mI-gp70
innormal serum or saline injected into normal BN rats i.v. exhibited
no preferential sequestration in any body organ.
It is possible that Protein A reduced the uptake of ICby spleen by
affecting antigen binding toits respective antibody. As shown inTable
3, Protein A has a slight but negligible effect on antigen binding.
Protein A,therefore, willbind to ICand alter their distribution in the
animal. Ithas been shown that Protein A is a T-cell mitogen (Nakaa
Table 1. Distribution ofcomplexes of l!SI-p3O-anti-p3O in tissues of rats.
Treatment and Tissue/Blood ratio: a>
Tissue Untreated DES C Trypan Blued Splenectomy e PAf
Spleen 48.7+14.4 27.3+4.6 23.5+4.6 4.0+0.4
Liver 2.8+0.1 2.5+0.4 4.7+1.7 1.9+0.1 2.5+0.3
Lung 0.8+0.03 0.8+0.03 0.8+0.05 0.7+0.03 0.8+0.1
L. Nodes 1.9+0.4 0.7+0.1 1.2+0.2 1.1+.2 0.7+0.2
Thynus 0.6+0.1 0.6+0.1 0.6+0.05 0.5+0.1 N.D.8
Kidney 3.0+0.3 4.0+0.6 3.8+0.7 2.2+0.1 3.5+0.5
a) CPM 125I-p30/100 mg tissue: CPM125I-p30/100 mg blood neasured 24 hours
after i.v. injection of 10 ng p30 contained in50 ul BN anti-p30,
average of 3-4 rats +_ S.E.
b) If 5I-p30 was injected withnormal BN serum, ratios greater than
1.0 were not seen in any tissue, except kidney.
c) Diethylstilbestrol, 100 mg/kg dissolved in ETOH and injected i.p.
3 days before complexes (RES stinulant).
d) 50 mg i.p. at minus 24 hours and 10 mg at minus 4 hours before
complexes (RES depressant).
e) 2 days prior to injection of complexes
f) Protein A, 0.5 mg mixed with complexes (average of 7 rats).
g) Not done.
Table 2. Effect of protein A on distribution of immune complexes
containing gp70.
Blood ratio at 24 hrs in:
et al., 1980) so it could also alter the lymphoidtissues ofanimals. The
mechanism of the effect of Protein Ais currently under investigation.
Further studies willbe required to determine whether the alteration
by Protein A of the in vivo distribution of IC will benefit animals
suffering from the pathological effects of immune complexes. We
observed no gross toxic effects for rats treated with up to 1mg Protein
Ai.v.Protein Ahas been reported to be non-toxic to rats and rabbits,
but to exhibit toxic activity forguinea pigs and humans (Martin et al.,
1967; Gustafson et al., 1968). Procedures that wouldreduce any toxic
properties must be developed before Protein Acould be administered
to humans.
Figure 2. Effect ofprotein Aon uptake of ICby spleen. Rats injected
i.v.with IC (20 ng mI-p30 + 100 ix\ BNanti-p30) alone or mixed with
500 ii% PA, or with l2!I-p30 in normal BN serum (NBN). Values
plotted are blood ratios ofspleen measured at 10 min., 1 hour, 4hours,
1day and 8 days post injectionof IC,average of4animals/ point ± S.E.











I-gp70 in saline 3 0.65+O 1.34+0.1 0.98+0.1 0.56*0.02 + pA 2Q125
I-gp7O in ICb 21.42.9.4 1.40+0.2 O.79±O.O4 0.72+0.08 RAPA 4M
1.3(M).l 0.86JO.1 0.76,0.02 0.80^0.08 a) . w. __ m
a) 0.5 ug I-gp70 of MiLV. b) Protein A, 25ug incubated with antibody before addition of
b) Iirnune complexes, 0.5 yg I-gp70 + 200 yl hyperiitmjne BN anti-gp 70.
c) IC mixed with 1.0 mg protein A.
antigen (125I-p3O).
c) 200 pi; GAR = Goat anti-rat globulin, RAPA = Rabbit anti-Protein A.
d) Percent of 1ng I-p30 precipitated in30 minutes, average of 2 tests.
d) CPM/g tissue: CPM/g blood, average 3-4 rats + S.E.
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